BNB Plus Corp.

BNBX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.50

-$0.03 (-4.85%)

Jun 10, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.85%

(1D)

Rating

Updated: Jun 8, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $645.68K

1D Range

0.49 0.52

52W Range

0.35 7.15

Valuation (TTM)

PE -0.01

PB 0.05

EV/EBITDA 0.01

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target N/A

Cash Flow

FCF Yield -2137.1%

SBC Adj. FCF Yield -2239.0%

SBC Impact -4.8%

Margins

Gross Margin 43.5%

Operating Margin -1209.5%

FCF Margin -659.2%

Growth (CAGR)

Revenue 3Y | 5Y -51.0% | N/A

Dil EPS 3Y | 5Y 32.9% | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -252.8%

ROE -337.1%

ROIC -204.1%

Financial Health

Net Cash

$949.09K

Current Ratio 1.82

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through ...

Sector Healthcare

Industry Biotechnology

Employees 46

IPO Date Oct 7, 2025

Website www.bnbx.io

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.